Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis

Objective: To describe postprandial lipemia in patients with rheumatoid arthritis (RA) and to analyze its association with subclinical atherosclerosis measured as carotid intima-media thickness (cIMT). Methods: We performed an observational study of 40 patients with RA and 40 sex and age-matched con...

ver descrição completa

Detalhes bibliográficos
Autores: Mena-Vázquez, Natalia, Rojas-Gimenez, Marta, Jimenez Nuñez, Francisco Gabriel, Manrique-Arija, Sara, Rioja, José, Ruiz-Limón, Patricia, Ureña, Inmaculada, Castro-Cabezas, Manuel, Valdivielso, Pedro, Fernández-Nebro, Antonio
Formato: artículo
Fecha de publicación:2020
País:España
Recursos:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/18089
Acesso em linha:http://hdl.handle.net/20.500.12105/18089
Access Level:acceso abierto
Palavra-chave:Rheumatoid arthritis
Postprandial lipemia
Apolipoprotein B48
Subclinical atherosclerosis
Cross-sectional studies
Artritis reumatoide
Apolipoproteína B-48
Aterosclerosis
Estudios transversales
Andalucía
Humans
Carotid Intima-Media Thickness
Apolipoprotein B-48
Fasting
Aminosalicylic Acids
Atherosclerosis
Arthritis, Rheumatoid
Hyperlipidemias
Triglycerides
Dyslipidemias
Endothelium
Cholesterol
Spain
Descrição
Resumo:Objective: To describe postprandial lipemia in patients with rheumatoid arthritis (RA) and to analyze its association with subclinical atherosclerosis measured as carotid intima-media thickness (cIMT). Methods: We performed an observational study of 40 patients with RA and 40 sex and age-matched controls. Patients with dyslipidemia were excluded. Pathologically increased cIMT was defined as a carotid thickness greater than the 90th percentile (>p90) for age and sex. Fasting and postprandial plasma lipids, cholesterol, triglycerides, apolipoprotein B48 (ApoB48), and total ApoB were evaluated. The other variables included were clinical and laboratory values, Framingham score, and the 28-joint Disease Activity Score (DAS28). Two multivariate models were constructed to identify factors associated with pathologic cIMT in patients with RA. Results: Fasting lipid values were similar in patients with RA and controls, although those of postprandial ApoB48 were higher (median (IQR), 14.4 (10.8–12.1) vs. 12.1 (2.3–9,8); p = 0.042). Pathologic cIMT was recorded in 10 patients with RA (25%) and nine controls (22.5%). In patients with RA, pathologic cIMT was associated with postprandial ApoB48 (OR (95% CI), 1.15 (1.0–1.3)) and total ApoB (OR [95% CI], 1.12 [1.1–1.2]). The second model revealed a mean increase of 0.256 mm for cIMT in patients with elevated anticitrullinated protein antibodies (ACPAs). Conclusion: Postprandial ApoB48 levels in patients with RA are higher than in controls. Postprandial ApoB48 and total ApoB levels and markers of severity, such as ACPAs, are associated with pathologic cIMT in patients with RA. Our findings could indicate that these atherogenic particles have a negative effect on the endothelium.